This announcement is a separate document:
杭州天目山药业股份有限公司关于2023年度向特定对象发行股票不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿的公告
Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on providing financial support or compensation to investors who issued shares to specific targets and did not participate directly or through stakeholders in the subscription in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.